目前转移性前列腺癌的治疗格局
Anastasia Bernal1, Alivia Jane Bechler1, Kabhilan Mohan1
1Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68106, USA.
Pharmaceuticals (Basel, Switzerland)
|March 28, 2024
概括
治疗新兴神经内分泌前列腺癌 (NEPC) 是前列腺癌的一种侵略性形式,缺乏经批准的治疗方法. 有前途的临床试验正在探索新的标,如AURKA和受体氨酸激酶,但需要更多的研究.
科学领域:
- 在瘤学瘤学.
- 翻译医学是一种翻译医学.
- 癌症研究 癌症研究
背景情况:
- 到2024年,前列腺癌 (PC) 将影响全球超过140万名患者,一些患者的标准治疗失败了.
- 治疗新兴神经内分泌前列腺癌 (NEPC) 是一种具有侵略性的亚型,目前没有批准的治疗方法.
- 有限的理解和治疗选择凸显了对NEPC管理的未满足需求.
研究的目的:
- 审查目前用于治疗晚期NEPC的临床试验方案.
- 为NEPC确定新的治疗点和组合策略.
- 评估新兴治疗方法对侵袭性前列腺癌的疗效.
主要方法:
- 编制和分析NEPC正在进行和已完成的临床试验.
- 对包括DLL3,EZH2,B7-H3,AURKA,受体氨酸激酶,PD-L1和PD-1在内的新目标的评估.
- 对各种治疗方法的治疗结果的评估.
主要成果:
- 阿利塞尔蒂布 (准AURKA) 和卡博赞丁尼布 (准受体氨酸激酶) 在NEPC治疗中显示出有前途的结果.
- 针对PD-1/PD-L1免疫检查点的试验表明有效性有限.
- 一些有前途的临床试验正在进行中,这表明NEPC正在积极研究.
结论:
- 目前有效的NEPC治疗环境有限,这凸显了对新型治疗策略的需求.
- 对NEPC的预防措施,诊断和生物标志物的进一步研究至关重要.
- 对NEPC的更深入的临床理解对于改善患者治疗结果至关重要.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


